Enlightenment Research, LLC

SEC CIK: 0001676924
Latest filing: Jan 24, 2023

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Enlightenment Research, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q4 2022 holdings

Shares (Q4 2022): 0; Sold out in Q4 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2021

Holdings of REGN by Enlightenment Research, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2022	0	$0	0.0%	−500−100.0%	Sold out	Holders
Q3 2022	500	$344.0K	0.8%	+500	New	Holders
Q4 2021	0	$0	0.0%	−1,100−100.0%	Sold out	Holders
Q3 2021	1,100	$666.0K	0.8%	+1,100	New	Holders